Three differentially expressed proteins, calreticulin, prohibitin and heat shock protein 60 (HSP60), which had not been reported in previous studies on ACC samples, were selected to be validated in a larger size of samples by immunishotchemistry. The gene discussed is CALR; the disease is adrenal cortex carcinoma.